- Home
- LE vs MGTX Comparison
LE vs MGTX Comparison
Compare LE & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LE | MGTX |
|---|---|---|
| Founded | 1963 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.2M | 610.1M |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LE | MGTX |
|---|---|---|
| Price | $16.58 | $7.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $32.50 | $23.83 |
| AVG Volume (30 Days) | 192.4K | ★ 298.8K |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.89 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,154,442,000.00 | $33,279,000.00 |
| Revenue This Year | $1.55 | N/A |
| Revenue Next Year | $2.38 | $569.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 137.42 |
| 52 Week Low | $7.65 | $4.73 |
| 52 Week High | $20.04 | $9.73 |
Technical Indicators
Market Signals| Indicator | LE | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 48.79 |
| Support Level | $13.72 | $7.23 |
| Resistance Level | $16.57 | $8.21 |
| Average True Range (ATR) | 1.01 | 0.30 |
| MACD | -0.30 | 0.02 |
| Stochastic Oscillator | 21.80 | 53.01 |
Price Performance
Historical ComparisonAbout LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.